Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007468
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007468
|
|---|---|
| Preferred Name | Penicillin G [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Penicillin G [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Penicillin G [Chemical/Ingredient]
|
| NUI |
N0000007468
|
| Synonym |
Benzylpenicillin
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-
|
| code |
C25288
|
| prefixIRI |
NDF-RT:N0000007468
|
| RxNorm_CUI |
7980
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0016133
|
| MeSH_DUI |
D010400
|
| type | |
| MeSH_Name |
Penicillin G
|
| UMLS_CUI |
C0030827
|
| RxNorm_Name |
Penicillin G
|
| Display_Name |
Penicillin G
|
| MeSH_Definition |
A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |